(0.48%) 5 246.68 points
(0.32%) 39 558 points
(0.75%) 16 511 points
(0.72%) $78.58
(-0.26%) $2.34
(0.11%) $2 362.50
(0.31%) $28.79
(1.77%) $1 063.10
(-0.01%) $0.924
(0.01%) $10.80
(-0.01%) $0.794
(-0.02%) $91.30
Live Chart Being Loaded With Signals
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation...
Stats | |
---|---|
Today's Volume | 111 641 |
Average Volume | 245 019 |
Market Cap | 7.05M |
EPS | $0 ( 2024-05-08 ) |
Next earnings date | ( $-0.0800 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.00500 (1.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Pham Quang X | Sell | 50 000 | Common Stock |
2024-04-02 | Cole Jeffrey Scott | Buy | 150 000 | Stock Options |
2022-08-01 | Cole Jeffrey Scott | Sell | 50 000 | Stock Options |
2025-02-01 | Cole Jeffrey Scott | Sell | 150 000 | Stock Options |
2023-10-23 | Pham Quang X | Sell | 85 000 | Common Stock |
INSIDER POWER |
---|
21.45 |
Last 37 transactions |
Buy: 1 884 792 | Sell: 1 964 584 |
Volume Correlation
Cadrenal Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cadrenal Therapeutics, Correlation - Currency/Commodity
Cadrenal Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 980.00 (0.00 %) |
EPS: | $-0.640 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 980.00 (0.00 %) |
EPS: | $-0.640 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-1 266.00 (0.00 %) |
EPS: | $-0.580 |
Financial Reports:
No articles found.
Cadrenal Therapeutics,
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators